177Lu-J591
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for 177Lu-J591, covering 2017-10-05 to 2023-07-19. Get the full timeline:
Most recent: Clinical Trial Update: 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer [Phase 2]